Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 170 results found. Search for [ SAIL Chairman ]

Results 160 to 170 of 170
Tejeesh N.S. Behl
October 14, 2008
What can go wrong? they asked last year. Well, this year, what hasn’t gone wrong? Result: fewer foreign tourists are visiting India this year.


Arnab Mitra and N. Madhavan
May 1, 2008
Steel and cement prices have appreciated over the last six months and led to runaway inflation. The government has alleged that companies in these sectors have formed cartels to keep prices high. How justified is the government angst? Or rather, is it a combination of factors that have conspired to push up prices? BT’s Arnab Mitra and N. Madhavan find out.


www.businesstoday.in
April 16, 2008
Mudra Group’s Bobby Pawar; ArcelorMittal’s Malay Mukherjee; Venkatramani Sumantran, Executive Vice Chairman, Hinduja Automotive; Dileep Choksi, former Vice Chairman, Deloitte Haskins & Sells; Pradeep Guha, CEO, Zee Entertainment Enterprises; and Sam Ghosh, CEO, Reliance Capital.


www.businesstoday.in
April 2, 2008
Mysore saree maker KSIC pulls itself out of the red.


Anusha Subramanian
March 4, 2008
A strong management with a hands-on approach is what separates GESCO from its peers in the industry.


Anusha Subramanian
January 5, 2008
With the arrival of Ferretti in India, luxury yachts are the topic of boardroom conversations. Which are the best yachts in India and how much do they cost? BT MORE helps you find out.


Rishi Joshi
November 28, 2007
Some of the biggest gainers on the stock market recently have been companies that most of us have probably never heard of. Which are these companies, what do they do and what’s so hot about them?


By Ritwik Mukherjee
October 17, 2007
Arcelor-Mittal and POSCO may have chosen its neighbouring states (Orissa and Jharkhand, respectively), but West Bengal has managed to become the #3 state for steel investment in the country.


By Mahesh Nayak
September 11, 2007
Strikes five deals worth $840 million in 12 months.


Manu Kaushik and Ritwik Mukherjee
August 29, 2007
India is where the action is in steel, write Manu Kaushik and Ritwik Mukherjee.


By E. Kumar Sharma
August 17, 2007
When Dr Reddy's labs announced last fortnight that its anti-diabetic molecule Balaglitazone had entered phase III clinical trials, it was easily one of the highest points of the Indian pharma sector's research & development (R&D) programme in a long time.


PAGES 9 OF 9  6789